To compare the antigen presentation capacity of DCs, BM-derived DCs were incubated with the supernatant from M05 tumor treated with IL PV-10 in the presence of HMGB1 neutralizing antibody or isotype antibody for 2 days. This evidence concerns the gene HMGB1 and neoplasm.